Alternative oral exemestane formulation: improved dissolution and permeation.

Alternative oral exemestane formulation: improved dissolution and permeation.

Item
http://www.wikidata.org/entity/Q33647516
Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs.Molecular buckets: cyclodextrins for oral cancer therapy.QbD based approach for optimization of Tenofovir disoproxil fumarate loaded liquid crystal precursor with improved permeability.HPLC Methods for Quantitation of Exemestane-Luteolin and Exemestane-Resveratrol Mixtures in Nanoformulations.Interaction between hydroxyethyl starch and propofol: computational and laboratorial study.Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.An overview on dry eye treatment: approaches for cyclosporin a delivery
P2860

Alternative oral exemestane formulation: improved dissolution and permeation.

Item
http://www.wikidata.org/entity/Q33647516
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alternative oral exemestane formulation: improved dissolution and permeation.
@ast
Alternative oral exemestane formulation: improved dissolution and permeation.
@en
type
label
Alternative oral exemestane formulation: improved dissolution and permeation.
@ast
Alternative oral exemestane formulation: improved dissolution and permeation.
@en
prefLabel
Alternative oral exemestane formulation: improved dissolution and permeation.
@ast
Alternative oral exemestane formulation: improved dissolution and permeation.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Alternative oral exemestane formulation: improved dissolution and permeation
@en
P2093
P304
P31
P356
10.1016/J.IJPHARM.2010.07.046
P407
P433
P478
P50
P577
P5875
P698